Gottlieb Adds A No. 2: Sherman Is US FDA Principal Deputy Commissioner
Rachel Sherman takes over a position that has not been filled permanently since Josh Sharfstein left in 2011.
You may also be interested in...
US FDA Taps Abernethy As Principal Deputy Commissioner; Health IT Exec Brings “Real-World” Expertise
Abernethy comes to FDA from Flatiron Health, which develops oncology-specific electronic health record software and real-world evidence for cancer research. She succeeds FDA veteran Rachel Sherman, who will retire from the agency in January.
Reorganization also may force change to commissioner succession plan.